Filing Flows › Abbott Laboratories (ABT) › Q1 2025
Abbott Laboratories (ABT) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 30, 2025
Abbott Laboratories (ABT) reported revenue of $10.4B for the first quarter 2025 (Q1 2025), +4% from a year earlier and -6% from the quarter before. Operating margin was 16.3%, net earnings $1.3B (12.8% of revenue).
Abbott Laboratories, Q1 2025: revenue $10.4B (+4% year over year), operating margin 16.3%, net earnings $1.3B, operating cash flow $1.4B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.4B | -6% | +4% |
| Operating profit | $1.7B | -11% | +22% |
| Net earnings | $1.3B | -86% | +8% |
| Operating cash flow | $1.4B | -51% | +38% |
| Free cash flow | $933M | -57% | +49% |
What changed
Revenue was $10.4B in Q1 2025, up 4% year over year and down 6% from the previous quarter.
Operating profit was $1.7B, a 16.3% margin (up 2.4 points year over year). Of the extra revenue versus a year earlier, 78% reached operating profit, above the 14% margin then. Total costs grew 1% against revenue growth of 4%. Net earnings were $1.3B, up 8% year over year. The effective tax rate was 25.5%.
Operating cash flow was $1.4B (up 38% year over year), 107% of net earnings. Non-cash charges added back $0.76B of depreciation and amortization and $0.29B of share-based compensation. Working capital and other items used $1.0B. Capital expenditures of $0.48B left free cash flow of $0.93B.
Questions
What was Abbott Laboratories' revenue in the first quarter 2025?
Abbott Laboratories (ABT) reported revenue of $10.4B for the first quarter 2025 (Q1 2025), +4% from a year earlier and -6% from the quarter before.
Was Abbott Laboratories profitable in the first quarter 2025?
Operating profit was $1.7B (16.3% of revenue) and net earnings $1.3B.